Reasons for Declining to Enroll in a Phase I and II HIV Vaccine Trial after Randomization among Eligible Volunteers in Dar es Salaam, Tanzania

• Edith A. M. Tarimo ,

  * E-mail: etarimo54@yahoo.co.uk

  Affiliations Division of Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden, Department of Nursing Management, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Anna Thorson,

  Affiliation Division of Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Thecla W. Kohi,

  Affiliation Department of Nursing Management, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Muhammad Bakari,

  Affiliation Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Fred Mhalu,

  Affiliation Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Asli Kulane

  Affiliation Division of Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden

  ⨯